Prime Medicine, Inc. (PRME)
3.56
+0.31
(+9.54%)
USD |
NASDAQ |
Aug 25, 12:49
Prime Medicine Price to Book Value : 16.16 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 14.76 |
| August 21, 2026 | 15.39 |
| August 20, 2026 | 14.71 |
| August 19, 2026 | 16.07 |
| August 18, 2026 | 13.85 |
| August 17, 2026 | 14.39 |
| August 14, 2026 | 14.03 |
| August 13, 2026 | 14.39 |
| August 12, 2026 | 14.53 |
| August 11, 2026 | 14.80 |
| August 10, 2026 | 14.30 |
| August 07, 2026 | 13.98 |
| August 06, 2026 | 13.39 |
| August 05, 2026 | 13.98 |
| August 04, 2026 | 13.53 |
| August 03, 2026 | 12.76 |
| July 31, 2026 | 13.26 |
| July 30, 2026 | 13.71 |
| July 29, 2026 | 13.76 |
| July 28, 2026 | 14.03 |
| July 27, 2026 | 13.67 |
| July 24, 2026 | 13.39 |
| July 23, 2026 | 13.48 |
| July 22, 2026 | 14.03 |
| July 21, 2026 | 14.17 |
| Date | Value |
|---|---|
| July 20, 2026 | 13.85 |
| July 17, 2026 | 14.21 |
| July 16, 2026 | 14.62 |
| July 15, 2026 | 15.84 |
| July 14, 2026 | 15.75 |
| July 13, 2026 | 15.96 |
| July 10, 2026 | 17.16 |
| July 09, 2026 | 19.20 |
| July 08, 2026 | 20.98 |
| July 07, 2026 | 18.11 |
| July 06, 2026 | 18.11 |
| July 02, 2026 | 17.57 |
| July 01, 2026 | 17.66 |
| June 30, 2026 | 16.75 |
| June 29, 2026 | 8.760 |
| June 26, 2026 | 8.077 |
| June 25, 2026 | 7.488 |
| June 24, 2026 | 7.347 |
| June 23, 2026 | 7.630 |
| June 22, 2026 | 7.936 |
| June 18, 2026 | 7.606 |
| June 17, 2026 | 7.441 |
| June 16, 2026 | 6.758 |
| June 15, 2026 | 6.829 |
| June 12, 2026 | 6.535 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Beam Therapeutics, Inc. | 2.990 |
| Twist Bioscience Corp. | 21.64 |
| Sana Biotechnology, Inc. | 7.804 |
| Generate Biomedicines, Inc. | 5.589 |
| Intellia Therapeutics, Inc. | 2.590 |
Price to Book Value Related Metrics
| PS Ratio | 151.94 |
| Price | 3.56 |
| Earnings Yield | -30.49% |
| Market Cap | 643.43M |